Created at Source Raw Value Validated value
Feb. 25, 2022, noon oms

Moderate and severe COVID-19 patients <br/ > Patients with abnormal chest imaging <br/ > Patients who are administered with anti-SARS-CoV-2 monoclonal antibodies <br/ > Patients who are on metformin or atorvastatin currently and in the past one month <br/ > Type 2 diabetes mellitus and pre-diabetes patients <br/ > Patients with primary and/or secondary dyslipidemia <br/ > Patients who are on corticosteroids or immunosuppressants <br/ > Patients with history of known hypoglycemic episodes in the past <br/ > Patients with clinically significant lung, heart, liver or kidney disease <br/ > Patients on alternative systems of medicine <br/ > Patients with known allergic history to metformin or atorvastatin <br/ > Pregnant or breastfeeding woman

Moderate and severe COVID-19 patients <br/ > Patients with abnormal chest imaging <br/ > Patients who are administered with anti-SARS-CoV-2 monoclonal antibodies <br/ > Patients who are on metformin or atorvastatin currently and in the past one month <br/ > Type 2 diabetes mellitus and pre-diabetes patients <br/ > Patients with primary and/or secondary dyslipidemia <br/ > Patients who are on corticosteroids or immunosuppressants <br/ > Patients with history of known hypoglycemic episodes in the past <br/ > Patients with clinically significant lung, heart, liver or kidney disease <br/ > Patients on alternative systems of medicine <br/ > Patients with known allergic history to metformin or atorvastatin <br/ > Pregnant or breastfeeding woman